A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors — Stella

Home/Mesothelin Positive Tumors/

View on ClinicalTrials.gov

Recruiting

Back to Mesothelin Positive Tumors trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

Nanjing Calmhome Cell and Gene Engineering Institute Co., Ltd.

Enrollment target

~24 participants

Started

May 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.